Key facts
- This page summarizes Shruthi Narayan's Form 4 filing for Penumbra Inc (PEN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Aug 2026, 19:23.
Shruthi Narayan - 17 Aug 2026 Form 4 Insider Report for Penumbra Inc (PEN)
- Reporting relationship
- President
- Issuer ticker
- PEN
- Reported as of
- 17 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Aug 2026, 19:23:17 UTC
- Prior SEC filing
- 17 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Johanna Roberts, as attorney-in-fact for Shruthi Narayan
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Shruthi Narayan filed Form 4 for Penumbra Inc (PEN) on 19 Aug 2026.
Change
- Previous filing in this sequence was filed on 17 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002086163
Primary reporting owner
Narayan Shruthi
- Relationship
- President
- Address
- ONE PENUMBRA PLACE, ALAMEDA
- Signature
- /s/ Johanna Roberts, as attorney-in-fact for Shruthi Narayan
- Signature date
- 19 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PEN
transaction
Common Stock
Award
- Transaction value
- Shares
- +3,060
- Change %
- +9.9%
- Price
- $0.000000*
- Shares after
- 33,880
- Date
- 17 Aug 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On August 17, 2026, the Reporting Person was granted 3,060 restricted stock units ("RSUs") under the Issuer's Amended and Restated 2014 Equity Incentive Plan, of which 1/4 of the RSUs (each, an "Equity Grant Tranche") will vest equally on an annual basis, beginning on August 15, 2027, subject to continued service by the Reporting Person on the applicable vesting date. Notwithstanding the foregoing, if the Closing (as defined in that certain Agreement and Plan of Merger, dated as of January 14, 2026, among the Issuer, Boston Scientific Corporation and Pinehurst Merger Sub, Inc.) occurs, the RSUs will vest as follows: the first two Equity Grant Tranches (to the extent not already vested) shall vest on the Closing, and the last two Equity Grant Tranches (to the extent not already vested) shall vest on the first and second anniversaries of the Closing, respectively, subject to continued service by the Reporting Person on the applicable vesting date.
Footnote F2
A portion of these shares is subject to vesting.
Footnote F3
Includes 65 shares purchased by the Reporting Person under the Issuer's Employee Stock Purchase Plan on May 19, 2026.